Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
2008 · Cancer Research · 388 citations
https://doi.org/10.1158/0008-5472.can-08-0499
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
382
Citations
1
h-index
1
i10-index
Dong-geng Liu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Drug Transport and Resistance Mechanisms & Cancer therapeutics and mechanisms. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat